| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/1989 | WO1989000191A1 Novel thrombolytic proteins |
| 01/12/1989 | WO1989000168A1 Novel interleukin-2 receptor and applications thereof |
| 01/12/1989 | WO1989000167A1 Proteins and protein compositions and their use |
| 01/12/1989 | WO1989000166A2 Growth hormone related peptide |
| 01/12/1989 | WO1989000164A1 Chondrocyte-specific membrane proteins and process for diagnosis and monitoring of autoimmune reactions against chondrocytes |
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes |
| 01/12/1989 | WO1989000161A1 Malic acid derivative containing renin inhibiting peptides |
| 01/12/1989 | WO1989000080A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 01/12/1989 | WO1989000051A1 Fibrin-binding compound and method |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/12/1989 | WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/12/1989 | WO1989000043A1 Ophthalmic agent and related compositions and method for treatment of the cornea |
| 01/12/1989 | WO1988009818A3 Growth hormone receptor |
| 01/12/1989 | WO1988009809A3 Cell system for expression of recombinant protein without production of virus |
| 01/12/1989 | WO1988009780A3 Polypeptide compounds having growth hormone releasing activity |
| 01/12/1989 | DE3820770A1 Polypeptides |
| 01/12/1989 | DE3721790A1 Knorpelzellspezifische membranproteine und verfahren zur diagnose und verlaufskontrolle von autoimmunreaktionen gegen knorpelzellen Chondrocyte-specific membrane proteins and methods for the diagnosis and monitoring of autoimmune reactions against cartilage cells |
| 01/12/1989 | DE3721637A1 Gaseinlass fuer eine mehrzahl verschiedener reaktionsgase in reaktionsgefaesse Gas inlet for a plurality of different reactive gases in reaktionsgefaesse |
| 01/11/1989 | EP0298820A1 Peptide derivatives and their therapeutic application |
| 01/11/1989 | EP0298807A1 Method for the production of stable cell lines from transgenic animals for the production of specific proteins; tumour cell lines and proteins obtained |
| 01/11/1989 | EP0298755A1 Protein conjugates and their preparation |
| 01/11/1989 | EP0298732A2 Therapeutic Somatostatin analogues |
| 01/11/1989 | EP0298723A1 Recombinant fibroblast growth factors |
| 01/11/1989 | EP0298654A2 Use of antibody/antigen interactions to protect or modulate biological activity |
| 01/11/1989 | EP0298645A2 Polypeptide possessing maltotetraose-forming amylase activity, and its uses |
| 01/11/1989 | EP0298633A2 Synthetic polypeptides |
| 01/11/1989 | EP0298555A1 Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 01/11/1989 | EP0298553A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 01/11/1989 | EP0298474A2 Novel calcitonin derivative and salt thereof |
| 01/11/1989 | EP0298210A2 Method for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and reagents used therefor |
| 01/11/1989 | EP0298101A1 Thiol-reactive cross-linking reagents |
| 01/11/1989 | CN1030255A Transgenic animals |
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates |
| 01/10/1989 | US4797491 Spacers; biochemical |
| 01/10/1989 | US4797474 Solubilization of protein aggregates |
| 01/10/1989 | US4797471 Inhibiting colagen synthesis |
| 01/10/1989 | US4797469 Synthesis of hGRF (Somatocrinin) in liquid phase and intermediate peptides |
| 01/10/1989 | US4797370 Antigens, bonding, immunology |
| 01/10/1989 | US4797368 Plasmids, dna, packages |
| 01/10/1989 | US4797359 Genetic engineering, dna |
| 01/10/1989 | US4797356 Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays |
| 01/10/1989 | US4797279 Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis |
| 01/10/1989 | US4797276 Produces insecticidal endotoxins |
| 01/10/1989 | US4797234 Production of sustained release composition from salt-form reactants |
| 01/10/1989 | CA1248700A1 Gnrh agonists |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/10/1989 | CA1248449A1 Process for purifying factor viii: c |
| 01/10/1989 | CA1248448A1 PURIFICATION OF BIOLOGICALLY ACTIVE HUMAN IMMUNE INTERFERON-.gamma. |
| 01/04/1989 | EP0297972A2 Process for preparing organised collagen structures, especially those of human origin, and the collagenous structures |
| 01/04/1989 | EP0297924A2 Recombinant vaccinia virus expressing HSV 1 gB |
| 01/04/1989 | EP0297913A2 Production of Kallikrein |
| 01/04/1989 | EP0297912A2 Process for immobilization |
| 01/04/1989 | EP0297882A2 Hybrid plasminogen activators |
| 01/04/1989 | EP0297834A2 Alpha-amylase inhibitor |
| 01/04/1989 | EP0297833A2 Physiologically active lymphotoxin |
| 01/04/1989 | EP0297816A2 Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| 01/04/1989 | EP0297815A2 Fluorine containing renin inhibitors |
| 01/04/1989 | EP0297807A1 Novel prokaryotic expression and secretion system |
| 01/04/1989 | EP0297641A1 Guanidine-compounds containing a substituted tetraphenylborate ion, process for obtaining these compounds and the use of these compounds in peptid synthesis |
| 01/04/1989 | EP0297585A2 Neuronal polypeptide and methods of production and use thereof |
| 01/04/1989 | EP0297456A2 Immunosuppressant peptides |
| 01/04/1989 | EP0297362A2 Human aprotinine whose Lys residue in position 15 is substituted by another protogene redisue of amino-acid |
| 01/04/1989 | EP0297291A2 Outer membrane protein F of Pseudomonas aeruginosa |
| 01/04/1989 | EP0297262A2 Synthetic gene coding for a growth factor |
| 01/04/1989 | EP0297159A1 [N-Acyl, 1,7-Di-Aline] calcitonins, method for their preparation, pharmaceutical compositions and use |
| 01/04/1989 | EP0297110A1 Polypeptides providing protective immunity against malaria |
| 01/04/1989 | CN1030093A Production of peptide |
| 01/03/1989 | US4795822 Antidepressant |
| 01/03/1989 | US4795806 Phospholipid affinity purification of Factor VIII:C |
| 01/03/1989 | US4795805 Derivative of adult T cell leukemia virus antigen peptide |
| 01/03/1989 | US4795804 Polypeptide |
| 01/03/1989 | US4795803 Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 01/03/1989 | US4795740 Antiviral peptides and means for treating herpes infections |
| 01/03/1989 | US4795739 Administering protein |
| 01/03/1989 | US4795709 Enzymes from yeasts, polychlorohydrocarbons |
| 01/03/1989 | US4795706 Novel expression control sequences |
| 01/03/1989 | CA1248300A1 Method for promoting disulfide bond formation in recombinant proteins |
| 01/03/1989 | CA1248299A1 Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation |
| 01/03/1989 | CA1248296A1 Inhibitors of mammalian collagenase |
| 01/03/1989 | CA1248090A1 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 01/03/1989 | CA1248089A1 Analgesic peptide and process for the preparation thereof |
| 12/29/1988 | WO1988010311A1 Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 12/29/1988 | WO1988010310A1 Bovine granulocyte-macrophage colony stimulating factor |
| 12/29/1988 | WO1988010308A1 Pheromone-inducible yeast promoter |
| 12/29/1988 | WO1988010307A1 Balanced constitutive inducible transcription system |
| 12/29/1988 | WO1988010306A1 Cloned protein g variant genes and the protein g variants expressed therefrom |
| 12/29/1988 | WO1988010305A1 New toxin-encoding dna fragments from bacillus thuringiensis subsp. israelensis |
| 12/29/1988 | WO1988010303A1 Preparation of novel protein sweeteners |
| 12/29/1988 | WO1988010302A1 Novel plasmid, microbial cells, process for preparing polypeptide with oncostatic activity, and secreted polypeptide with oncostatic activity |
| 12/29/1988 | WO1988010301A1 Hepatitis b surface antigen vaccine |
| 12/29/1988 | WO1988010300A1 Heterologous viral peptide particle immunogens |
| 12/29/1988 | WO1988010299A1 A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
| 12/29/1988 | WO1988010298A1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 12/29/1988 | WO1988010297A1 Cloning of mite allergens |
| 12/29/1988 | WO1988010271A1 Preparation of novel protein sweeteners |
| 12/29/1988 | WO1988010270A1 Urinary follicle stimulating hormone |
| 12/29/1988 | WO1988010269A1 Growth factors |
| 12/29/1988 | WO1988010268A1 Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract |
| 12/29/1988 | WO1988010267A1 Synthetic peptides related to hiv-env proteins |
| 12/29/1988 | WO1988010266A1 Cysteine proteinase inhibitor |